tiprankstipranks
pc:ansab

Ansa Biotechnologies Inc

Ansa Biotechnologies Inc, headquartered in Emeryville, California, is revolutionizing DNA synthesis through its proprietary enzymatic platform. The company offers a sustainable approach that enables the synthesis of longer and more complex DNA sequences without harsh chemicals, thus preserving DNA integrity. Ansa's innovative technology supports advancements in gene and cell therapy, vaccines, agrigenomics, and synthetic biology, empowering scientists to accelerate discoveries and design at scale. With a commitment to quality and customer satisfaction, Ansa provides sequence-perfect clonal DNA and sequence-verified linear double-stranded DNA fragments, facilitating the industry's transition from genome reading to writing.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$54M
Total Amount Raised$54M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$54M
Latest Funding Amount$54M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 08, 2025
Series B
$54.40M

Investors

Related News and Analysis